Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation

Next Previous
X
Search
Trial Profile

A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin With Factorial Evaluation of Irbesartan for the Prevention of Vascular Events in Patients With Atrial Fibrillation

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Aug 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Myocardial infarction; Stroke; Thromboembolism; Vascular disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ACTIVE; ACTIVE-W
  • Sponsors Sanofi

    • Most Recent Events

    • 04 Aug 2019 Results (n=962) of post-hoc analysis assessing thrombooembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment of this and ACTIVE-A trial published in the European Heart Journal
    • 14 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association (AHA 2009).
    • 20 Oct 2009 Actual patient number (6706) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top